06Jun
Supreme Court Decides Prescription Drug Preemption Case in Favor of Drug Manufacturer
The United States Supreme Court finally clarified its 11-year-old “clear evidence” standard for pharmaceutical preemption. In its much-anticipated opinion delivered by Justice Breyer, the Court unanimously reversed the Third Circuit’s holding that...
By:
Morrison & Foerster LLP - Class Dismissed
Related
In today’s edition of Daily Compliance News: 1. Should Fed rethink its mandate. (WaPo) 2. Business...
Read More >
When preparing for a construction project, one of the first decisions that must be made is whether t...
Read More >
Last summer, we advised that the Pennsylvania legislature was considering a bill that would require ...
Read More >
Report on Supply Chain Compliance 2, no. 21 (November 7, 2019) - The deadline for compliance with a...
Read More >
On July 31, 2019, Illinois joined a growing list of state and local governments that have banned emp...
Read More >
Owners, contractors and subcontractors across the country are encountering delays arising from the C...
Read More >